Subscribe To
Peripheral angioplasty market valued at us$ 3.4 billion in 2023, poised to reach us$ 7.2 billion by 2033, fueled by rising demand for minimally invasive pad treatments | future market insights, inc.
Peripheral arterial disease affects a considerable portion of the global population, particularly elderly individuals and those with risk factors like...
July 18, 2023, 1:30 pm
Acumen: a first in targeting, may lead to improvement for early ad patients
Positive topline results released from phase 1 INTERCEPT-AD study, which used ACU193 for the treatment of patients with early AD. The global market fo...
July 18, 2023, 8:34 am
Pfizer and flagship pioneering to invest $100 million to develop treatments for unmet medical needs
Pfizer Inc. PFE, -1.27% and Flagship Pioneering said Tuesday they are investing a total of $100 million upfront to explore opportunities to develop 10...
July 18, 2023, 7:10 am
Is it too late to buy eli lilly stock?
Shares of Eli Lilly have soared 44% since the end of February. Eli Lilly's latest acquisition target was developing a drug that could work alongside O...
July 18, 2023, 5:26 am
Turnstone biologics to offer 5.8 million shares in planned ipo priced at $12 to $14 each
Turnstone Biologics TSBX, , a clinical-stage biotech that specializes in treatments for solid tumors, s...
July 17, 2023, 6:35 am
Oxford cannabinoid jumps as firm hints cheaper cancer treatments
Shares in Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) rose 10% on Monday as the pharmaceutical company formally announced its...
July 17, 2023, 6:06 am
Pulmonx to report second quarter 2023 financial results on august 2, 2023
REDWOOD CITY, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive
July 15, 2023, 2:02 am
Cara therapeutics faces uncertainty despite potential reimbursement extension for korsuva
Cara Therapeutics' Korsuva injection, approved for treating pruritus in adults with chronic kidney disease, may have its reimbursement period extended...
July 14, 2023, 5:11 pm
Wound care surfactants revolutionize wound healing treatments, fmi forecasts market to exceed us$ 1.0 billion by 2033
The Global Wound Care Surfactant Market is witnessing significant growth as the demand for advanced wound treatment solutions continues to rise, accor...
July 14, 2023, 11:30 am
Lly stock alert: what to know as eli lilly acquires versanis bio
Eli Lilly (NYSE: LLY ) stock is a hot topic among traders on Friday after the company announced its acquisition of Versanis Bio . Versanis Bio is a cl...
July 14, 2023, 10:29 am
Eli lilly to acquire versanis bio, expanding obesity-treatment pipeline
Eli Lilly and Co. LLY, -1.34% will acquire Versanis Bio, a private clinical-stage biopharma company focused on new ...
July 14, 2023, 8:14 am
The blazing weight-loss drug battle: can anyone unseat undisputed leaders novo nordisk and lilly?
An overweight world is hungry for obesity treatments, driving big forecasts for weight loss drugs. For ...
July 13, 2023, 1:37 pm
Nvidia and recursion pharmaceuticals team up on ai-based biotech collaboration
Tech giant NVIDIA Corporation (NASDAQ:NVDA) has dedicated US$50mln to a multi-year collaboration with US-listed biotech company Recursion Pharmaceutic...
July 13, 2023, 3:21 am
Numinus to present at the small cap growth virtual investor conference on july 13, 2023
VANCOUVER, BC , July 10, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) – a mental health care c...
July 10, 2023, 6:29 pm
Leqembi approval offers renewed hope for novel alzheimer's disease treatments
US officials have granted full approval to Leqembi, the first medication to demonstrate modest effectiveness in slowing cognitive decline associated w...
July 10, 2023, 4:43 pm
Sagimet biosciences sets ipo terms, to raise up to about $80 million
Sagimet Biosciences Inc. SGMT, disclosed Monday terms for its initial public offering, in which the California-based biopharmaceutical company focused...
July 10, 2023, 7:05 am
Apogee therapeutics sets ipo terms, to be valued at up to $774.5 mln
Apogee Therapeutics Inc. APGE, has set terms for its initial public offering, as the Massachusetts-based biotechnology company developing ...
July 10, 2023, 6:28 am
Replimune: the rise of oncolytic virus therapies in cancer treatment
The company's RPx platform, featuring RP1, RP2, and RP3, showcases a comprehensive and innovative approach to cancer treatment. Top-line results from ...
July 9, 2023, 1:22 am
Moderna shares advance after striking mrna drug development deal with china
Moderna shares rose 1.5% on Wednesday after signing an agreement with China to research, develop, and make mRNA ...
July 5, 2023, 5:05 pm
Aslan pharmaceuticals to host webcast on july 6, 2023, to discuss phase 2b topline data from trek-ad trial evaluating eblasakimab in atopic dermatitis
SAN MATEO, Calif. and SINGAPORE, July 05, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN”, Nasdaq: ASLN), a clinical-stage, immunology-foc...
July 5, 2023, 4:30 pm